Zevra Completes Acquisition of Acer Therapeutics: Read More Here.

Remain on Acertx.com

Skip to content

Product
Pipeline
- OLPRUVA™ Investigational Lifecycle Opportunities
- EDSIVO™ for vEDS
Patients & Physicians
Contact Us

About
Pipeline
Investor Relations
Publications
Contact Us

Investor FAQs
Analyst Coverage
Corporate Governance
Stock Information
Events & Presentations

About
Pipeline
Investor Relations
Publications
Contact Us

Stock Information

Investor Relations

ACER Chart by TradingView

Developing therapies for patients with serious, ultra-rare diseases

Stay Updated with Us

Name

First Last

Email(Required)

About
Pipeline
Investor Relations
Publications
Contact Us

Acer Terms & Conditions Privacy Policy

Copyright © 2022 | All Rights Reserved

QUICK
NAV

MENUMENU

About
Product
Pipeline
Patients & Physicians
Investor Relations
Contact Us

We use cookies to ensure that we give you the best experience on our website. By using our site, you consent to cookies. Learn more.Ok